Simply Wall St. - 2025-07-15 17:25
Cencora (COR) recently executed a distribution services agreement with Citius Oncology, signaling an expansion in its pharmaceutical distribution capabilities. Over the past quarter, Cencora’s share price rose by 4.4%, aligning with the market trend of major indexes reaching record highs. This gain is supported by several corporate actions, including strong second-quarter earnings and ongoing share buybacks, which may have bolstered investor confidence. The dividend announcement and...
